Novartis agreed to pay $390 million in October 2015 to settle claims that it paid rebates to specialty pharmacies to push two of its drugs, without admitting wrongdoing.
swissinfo.ch
Swiss pharmaceutical giant Novartis must face a United States government lawsuit accusing it of paying millions of dollars in kickbacks to doctors so they would prescribe its drugs, Reuters reported.
A federal judge in Manhattan ruled on Monday that the US government had offered evidence of a “company-wide kickback scheme.” It also ruled that the government does not need to prove a direct “quid pro quo” deal between medics and doctors for the company to be liable.
The ruling means Novartis is headed for a trial – unless it settles.
“We are disappointed in today’s decision and look forward to presenting our case at trial,” Novartis spokesman Eric Althoff said in an email statement quoted by Reuters. “We continue to believe that the government has insufficient evidence to support its claims.”
The case took shape in 2011 when Oswald Bilotta, a former Novartis sales representative, filed a whistleblower lawsuit. The US government and the state of New York both intervened in the case in 2013.
Hypertension drugs and alleged sham events
Novartis is accused of paying doctors kickbacks so they would prescribe drugs such as the hypertension drugs Lotrel and Valturna, as well as Starlix, which is used in the treatment of diabetes.
The lawsuit claims that those kickbacks included speaking fees for doctors at “sham” educational events. One doctor was reportedly paid to speak at his own office eight times.
Novartis allegedly treated doctors to lavish meals, including a $9,750 (CHF 9,750) dinner for three at a Japanese restaurant.
American health insurance programs Medicare and Medicaid were billed millions of dollars from 2002 to 2011 for drugs prescribed by doctors who took kickbacks, according to the lawsuit said.
The US government is seeking damages of three times what it was billed for allegedly fraudulent claims. Novartis has settled US allegations that it used illegal methods to promote its medicines in the past.
In 2010, Novartis paid $422 million to settle various allegations, including claims of paying kickbacks to doctors.
Novartis agreed to pay $390 million in October 2015 to settle claims that it paid rebates to specialty pharmacies to push two of its drugs, without admitting wrongdoing.
More
More
US, Japan file complaints against Novartis
This content was published on
The New Jersey-based company boosted its sales of the iron-reduction drug Exjade by giving referrals and rebates to pharmacy BioScrip, which recommended refills to its patients but often failed to warn them of the drug’s potentially fatal side effects. These include kidney failure and gastrointestinal haemorrhaging, according to the complaint filed in Manhattan federal court…
Swiss President Karin Keller-Sutter makes official visit to Austria
This content was published on
Karin Keller-Sutter, who took over the rotating Swiss presidency this year, has made her first official visit abroad as president to Austria.
This content was published on
The boss of Swiss Post, Roberto Cirillo, is stepping down at the end of March after six years in the job, the company announced on Friday.
This content was published on
The name and logo of the former Credit Suisse headquarters at Paradeplatz 8 in Zurich's financial centre were officially replaced by those of UBS on Friday.
Outgoing Swiss federal police chief warns of insufficient resources
This content was published on
The outgoing director of the Federal Office of Police (Fedpol), Nicoletta della Valle, has warned that officers, prosecutors and investigators in Switzerland have insufficient resources to do their work.
Swiss university inaugurates Europe’s most powerful centrifuge
This content was published on
The federal technology institute ETH Zurich has inaugurated Europe's most powerful geotechnical centrifuge. Researchers use the instrument to simulate the effects of natural hazards.
Swiss film industry reports successful year in 2024
This content was published on
Swiss films did well in cinemas in 2024, recording over 907,000 admissions, the Federal Statistical Office (FSO) reports. They accounted for almost 9% of all films shown last year in Switzerland.
Glencore and Rio Tinto held talks on mining’s biggest-ever potential merger, say reports
This content was published on
The Swiss-based mining and commodities group Glencore and the British company Rio Tinto reportedly held early-stage talks last year about combining their businesses.
First municipalities begin Swiss-wide plastic packaging recycling scheme
This content was published on
A new collection system to recycle plastic packaging and drinks cartons has begun in a handful of Swiss municipalities - others should follow in the coming weeks.
This content was published on
Despite an ongoing restructuring programme, Swiss retail giant Migros continued to grow last year by 1.6%, posting record sales of CHF32.5 billion ($35.7 billion).
Swiss researchers warn ‘mega-droughts’ are spreading around the world
This content was published on
"Mega-droughts" are increasing worldwide - becoming more frequent, hotter and more widespread over the past 40 years, a study published on Thursday shows.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Novartis hit by second US lawsuit in four days
This content was published on
On Friday, US Attorney Preet Bharara in Manhattan said the government had joined a whistle-blower lawsuit filed against Novartis Pharmaceuticals Corp in January 2011 which seeks triple damages under the federal False Claims Act. The government accused Novartis of causing the Medicare and Medicaid programmes to pay millions of dollars in reimbursements based on kickback-tainted…
This content was published on
The civil healthcare fraud lawsuit filed on Tuesday in a US district court in New York seeks unspecified damages and civil penalties for a scheme that the government said has been carried out since 2005. US Attorney Preet Bharara said in a statement the company used the “lure of kickbacks disguised as rebates” to turn…
Justice ministry confirms legal aid requests in Greece-Novartis scandal
This content was published on
The Federal Office of Justice has received two requests for legal assistance from Greece and the United States linked to probes into Novartis.
This content was published on
The employees are believed to have offered illegal rebates and kickbacks to doctors amounting to 2.6 billion won (CHF 2.3 million) between 2011 and 2016. Altogether, 34 people – including 15 doctors and five heads of medical journals – have been included in the investigation, which began in February when authorities raided the Novartis Korea…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.